cupure logo
cancerbidensdoctorsprostate cancerbidenprostatediagnosiscommonsignsmedical

23andMe Sold To Biotechnology Company For $256 Million

The acquisition comes two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Comments

Health news